<SEC-DOCUMENT>0001610618-25-000080.txt : 20250807
<SEC-HEADER>0001610618-25-000080.hdr.sgml : 20250807
<ACCEPTANCE-DATETIME>20250807160924
ACCESSION NUMBER:		0001610618-25-000080
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250807
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250807
DATE AS OF CHANGE:		20250807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cidara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001610618
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				461537286
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		251194034

	BUSINESS ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-752-6170

	MAIL ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	K2 THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20140611
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cdtx-20250807.htm
<DESCRIPTION>CIDARA THERAPEUTICS, INC. FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a19b0fe1-2faa-41a6-8353-985026f91d97,g:66a854f2-2067-4b99-a598-319b918d4e4d,d:f5fa30320b094feda29c5876487a8ac8-->
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cdtx-20250807</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001610618</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cdtx-20250807.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001610618</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-07</xbrli:startDate><xbrli:endDate>2025-08-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if5fa30320b094feda29c5876487a8ac8_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:12pt;text-align:center;text-indent:234pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center;text-indent:234pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August 7, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Cidara Therapeutics, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:234pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-36912</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">46-1537286</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">6310 Nancy Ridge Drive,</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 101</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">San Diego,</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">92121</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">858</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">752-6170</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, Par Value $0.0001 Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">CDTX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).&#160; </span></div><div style="margin-bottom:10pt;padding-left:121.5pt;text-indent:-121.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In this report, &#8220;Cidara Therapeutics,&#8221; &#8220;Cidara,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Cidara Therapeutics, Inc.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.02 Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 7, 2025, we issued a press release reporting our financial results for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">second</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> quarter ended June&#160;30, 2025.&#160;The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with General Instruction B.2 of Form 8-K, the information contained or incorporated herein, including the press release attached as Exhibit&#160;99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this Current Report on Form 8-K.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:91.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex9912025-08x07.htm">Press release issued August 7, 2025, reporting financial results for the second quarter ended June 30, 2025.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.755%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cidara Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:400;line-height:100%">Date: August 7, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey Stein, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey Stein, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex9912025-08x07.htm
<DESCRIPTION>EARNINGS RELEASE
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i09c81b97650e44bfbc2ba8a5ac492651_1"></div><div style="min-height:49.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 99.1</font></div></div><div><img alt="cdtxlogoa18a.jpg" src="cdtxlogoa18a.jpg" style="height:98px;margin-bottom:5pt;vertical-align:text-bottom;width:238px"></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Phase 2b NAVIGATE clinical trial evaluating CD388 for the prevention of seasonal influenza met primary and all secondary efficacy endpoints for all dose groups</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">End of Phase 2 meeting request submitted to the U.S. Food and Drug Administration (FDA)</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Closed upsized public offering for gross proceeds of $402.5 million&#59; significantly strengthened balance sheet to conduct planned Phase 3 program for CD388</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Added to Russell 2000</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.82pt;font-weight:700;line-height:120%;position:relative;top:-3.67pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> and Russell 3000</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.82pt;font-weight:700;line-height:120%;position:relative;top:-3.67pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> Indexes</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Conference call and webcast today at 5&#58;00 PM Eastern Time</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">SAN DIEGO, August 7, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#8212;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> Cidara Therapeutics, Inc. (Nasdaq&#58; CDTX) (the Company or Cidara), a biotechnology company using its proprietary Cloudbreak</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.82pt;font-weight:400;line-height:120%;position:relative;top:-3.67pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> platform to develop drug-Fc conjugate (DFC) therapeutics, today reported financial results for the second quarter ended June&#160;30, 2025, and provided recent business updates.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8220;The highly compelling results of our Phase 2b NAVIGATE trial for CD388 and subsequent financing puts us in a position of strength to execute on our Phase 3 plan to examine the potential of CD388, a non-vaccine solution, to provide single-dose per season, universal protection against influenza in individuals at greatest risk from influenza,&#8221; said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara. &#8220;Our planned Phase 3 development program focuses initially on individuals with compromised immune systems or those at a heightened risk of severe illness due to underlying health conditions. We have submitted an End-of-Phase 2 meeting request to the FDA to discuss our planned Phase 3 study design and start timing.&#8221;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Recent and Expected Corporate Highlights</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Phase 2b NAVIGATE trial evaluating CD388 for the prevention of seasonal influenza generated positive top-line results in June 2025. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The study met its primary and all secondary efficacy endpoints for all dose groups. Single doses of 450mg, 300mg and 150mg of CD388 conferred 76.1%, 61.3% and 57.7% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo. The placebo attack rate was 2.8% for the primary endpoint, and a clear dose response for efficacy was observed. CD388 was well-tolerated with no safety signals observed, and there were no meaningful changes in safety across the dose groups and placebo. Loss to follow-up rates were low and similar in all arms. Full primary analysis details from the Phase 2b NAVIGATE trial are expected to be submitted to upcoming scientific conferences in 2025.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">End of Phase 2 meeting request submitted to the FDA in June 2025. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Based on the robust data from the Phase 2b NAVIGATE trial, Cidara has submitted an End of Phase 2 meeting request to the FDA to review the data and discuss the details of a proposed Phase 3 study focusing on large populations with the highest unmet need, which includes high-risk&#47;co-morbid and immune-compromised patients. We plan to initiate the Phase 3 study no later than in the spring of 2026 during the Southern Hemisphere influenza season, subject to FDA consultation on our study design.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:144%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Closed an upsized public offering for gross proceeds of $402.5 million in June 2025. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Cidara closed an underwritten public offering of 9,147,727 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,193,181 shares, at a price to the public of $44.00 per share. The gross proceeds to Cidara from the offering, before deducting underwriting discounts and commissions and offering expenses, were $402.5 million.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Company announces inclusion in the Russell 2000&#174; and Russell 3000&#174; Indexes in June 2025. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">In June 2025, Cidara was added to the Russell 2000</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> and Russell 3000</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> Indexes, further enhancing the Company&#8217;s visibility with the institutional investment community.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:14.33pt">Hosted virtual research and development (R&#38;D) Day to discuss CD388 as a potential universal, once-per-flu season preventative of seasonal and pandemic influenza in May 2025. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The event featured key opinion leaders Fred Hayden, MD, FACP (University of Virginia School of Medicine) and Rick Bright, PhD (Pandemic Prevention Institute, The Rockefeller Foundation), who joined company management to discuss CD388.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Second Quarter 2025 Financial Results</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.33pt">Cash, cash equivalents and restricted cash totaled $516.9 million as of June&#160;30, 2025, compared with $196.2 million as of December&#160;31, 2024.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.33pt">Collaboration revenue was zero for the three and six months ended June&#160;30, 2025, compared to $0.3 million and $1.3 million for the same periods in 2024, respectively. Collaboration revenue related to R&#38;D and clinical supply services provided to J&#38;J Innovative Medicine, previously Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson &#38; Johnson (Janssen), under our license and collaboration agreement with Janssen (the Janssen Collaboration Agreement) which was terminated upon the effectiveness of our license and technology transfer agreement with Janssen (the Janssen License Agreement) on April 24, 2024.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.33pt">Acquired in-process research and development (IPR&#38;D) expenses were zero</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">for the three and six months ended June&#160;30, 2025, compared to $84.9 million for the same periods in 2024. Acquired IPR&#38;D related to an upfront payment of $85.0&#160;million paid to Janssen under the Janssen License Agreement on April 24, 2024, plus $0.4&#160;million in direct transaction costs, offset by a gain of $0.5&#160;million to settle the preexisting Janssen Collaboration Agreement relationship.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.33pt">R&#38;D expenses were $24.8 million and $49.4 million for the three and six months ended June&#160;30, 2025, respectively, compared to $6.7 million and $12.6 million for the same periods in 2024, respectively. The increase in R&#38;D expenses is primarily due to higher expenses associated with our CD388 Phase 2b NAVIGATE study as well as CD388 development costs relating to our planned Phase 3 study, offset by lower nonclinical expenses associated with our Cloudbreak platform.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.33pt">General and administrative (G&#38;A) expenses were $6.5 million and $12.7 million for the three and six months ended June&#160;30, 2025, respectively, compared to $4.7&#160;million and $8.3 million for the same periods in 2024, respectively. The increase in G&#38;A expenses is primarily due to higher personnel costs relating to stock-based compensation, offset by lower audit fees and legal costs.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.33pt">During the three and six months ended June&#160;30, 2025, the Company determined that accrued indirect taxes relating to shipments of our former rezafungin assets totaling $3.9&#160;million and $9.4 million, respectively, were not due and payable upon voluntary disclosure and full compliance in certain jurisdictions and the associated liabilities and operating expenses were reversed as part of continuing operations. No indirect tax reversals were recorded during the same periods in 2024.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.33pt">Income from discontinued operations for the three and six months ended June&#160;30, 2025 was zero, compared to $3.0&#160;million and $0.9&#160;million</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">for the same periods in 2024, respectively. On April 24, 2024, the Company entered into an asset purchase agreement with Napp Pharmaceutical Group Limited (Napp), an affiliate of Mundipharma Medical Company, pursuant to which all rezafungin assets and related contracts were sold to Napp. All conditions of the sale were completed on April 24, 2024, and the financial results of rezafungin have been reported separately as discontinued operations.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:14.33pt">Net loss for the three and six months ended June&#160;30, 2025 was $25.7 million and $49.2&#160;million, respectively, compared to a net loss of $91.2&#160;million and $101.5 million for the same periods in 2024, respectively.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Second Quarter 2025 Conference Call and Webcast Details</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Cidara Therapeutics management will host a conference call and webcast beginning at 5&#58;00 pm ET &#47; 2&#58;00 pm PT today, August 7, 2025. A live webcast may be accessed </font><font style="color:#026dce;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;text-decoration:underline">here</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. The conference call can be accessed by dialing toll-free (844) 825-9789 or (412) 317-5180 (international). The passcode for the conference call is 10200740.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">A replay of the webcast will be archived on </font><font style="color:#026dce;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;text-decoration:underline">www.cidara.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> for one year under the &#8220;</font><font style="color:#026dce;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;text-decoration:underline">Events &#38; Presentations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221; tab in the Investors section of the company&#8217;s website.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">About Cidara Therapeutics</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Cidara Therapeutics is using its proprietary Cloudbreak</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.82pt;font-weight:400;line-height:120%;position:relative;top:-3.67pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> platform to develop novel DFCs comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment. Cidara&#8217;s lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation. In June 2023, CD388 was granted Fast Track Designation by the FDA. Cidara announced positive top-line results from its Phase 2b NAVIGATE trial in June 2025. Additional DFCs have been developed for oncology and in July 2024 Cidara received investigational new drug application clearance for CBO421 which is intended to target CD73 in solid tumors. Cidara is headquartered in San Diego, California. For more information, please visit </font><font style="color:#026dce;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;text-decoration:underline">www.cidara.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">This release contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. &#8220;Forward-looking statements&#8221; describe future expectations, plans, results, or strategies and are generally preceded by words such as &#8220;anticipates,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221; &#8220;believes,&#8221; &#8220;may,&#8221; &#8220;plan&#8221; or &#8220;will&#8221;. Forward-looking statements in this release include, but are not limited to, statements related to the potential benefits of and future plans for CD388, a planned Phase 3 trial of CD388, the strength and impact of the Phase 2b NAVIGATE trial results and Cidara&#8217;s subsequent financing, and the expected timing for presenting full primary analysis details from the Phase 2b NAVIGATE trial. Such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, such as unanticipated delays in or negative results from Cidara&#8217;s clinical trials and other risks related to clinical development, the results of Cidara&#8217;s End-of-Phase 2 meeting with the FDA, delays in action by regulatory authorities, other obstacles associated with the enrollment of patients or other aspects of CD388 or other DFC development, having to use cash in ways other than as expected and other risks and uncertainties associated with Cidara&#8217;s business in general. These and other risks are identified under the caption &#8220;Risk Factors&#8221; in Cidara&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025 and other filings subsequently made with the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management&#8217;s assumptions and estimates as of such date. Cidara does not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">INVESTOR CONTACT&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Brian Ritchie</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">LifeSci Advisors</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(212) 915-2578</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">britchie&#64;lifesciadvisors.com</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">MEDIA CONTACT&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Michael Fitzhugh</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">LifeSci Communications</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">(628) 234-3889</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">mfitzhugh&#64;lifescicomms.com</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">CIDARA THERAPEUTICS, INC.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations (unaudited)</font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except share and per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaboration revenue</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,275&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,275&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired in-process research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,883&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,883&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,817&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,657&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,417&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,576&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,502&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,746&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,681&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,342&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reversal due to settlement of indirect tax liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,935)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,445)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,384&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,286&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,653&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,801&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,384)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,984)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,653)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104,526)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,666&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,774&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,565&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,139&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income, net</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,666&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,774&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,455&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,139&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss from continuing operations</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,718)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(94,210)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,198)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102,387)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations (including loss on disposal of discontinued operations of $1,799 during the three and six months ended June 30, 2024), net of income taxes</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,001&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">852&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss and comprehensive loss</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,718)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91,209)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,198)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,535)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted net loss per common share from continuing operations</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.65)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.65)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.31)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.50)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted net earnings per common share from discontinued operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.66&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.19&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted net loss per common share</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.65)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.99)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.31)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.31)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute basic and diluted net loss per common share</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,547,403&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,563,772&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,866,349&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,550,774&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><font><br></font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheet Data</font></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(unaudited)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">516,913&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,177&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,327&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,796&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,154&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,488&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,173&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,308&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cdtx-20250807.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a19b0fe1-2faa-41a6-8353-985026f91d97,g:66a854f2-2067-4b99-a598-319b918d4e4d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cdtx="http://cidara.com/20250807" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cidara.com/20250807">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdtx-20250807_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdtx-20250807_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://cidara.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cdtx-20250807_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a19b0fe1-2faa-41a6-8353-985026f91d97,g:66a854f2-2067-4b99-a598-319b918d4e4d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_fb76768f-8082-4b96-abe5-fbb1708a6979_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_ffd6e0b5-2574-4a29-969c-6bb77def7d4b_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f5268e0e-0294-434e-87cc-e0edf5cb9a73_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_577806d3-19c0-4cc9-8c88-6f4fe32ea8e0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ca0f2d20-0ce4-4dd7-894e-e4506f8d1a32_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ee360aef-af89-4a3f-bff5-b5c546f4520d_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_059e9a2c-22da-4029-9bc2-5a8ff4d5192e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_51d7ba9e-7310-4afc-b489-2a1bb12cb4e7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_beffccc4-cf2e-474a-9591-7ab5ca569bd2_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b79d8d3c-0741-4bd4-b9d4-20c49f382b38_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_024b1977-895e-40fb-a134-2f41f400c1e4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_41ab8307-5bc7-42a1-b25d-36bb2c307116_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bcf9b181-dca9-460a-b167-7418536a2c14_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_aecd4023-5877-4b63-9d76-5244c90c886a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cbc7f1b8-30c3-4e33-afa6-c9e998608bde_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a66e9086-ded1-4dc6-930f-b655513534df_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_dcb72972-aebb-4765-9a4a-f09437420253_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_85db8d07-8a8f-4be6-927f-9c3862bf8884_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_700c3a89-bc63-4d4e-a46c-2e60e5c27f8f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_72512eae-1027-464b-ad22-f3471d5fc306_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d9f95da8-3388-40c1-b8f1-d42b5316137b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_398035a9-1558-4323-b581-798907386479_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_803ab271-34de-4ba3-b8b3-2d73bf9071a6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_92820485-48ea-4ccf-8af0-3315a184c2d9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cdtx-20250807_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a19b0fe1-2faa-41a6-8353-985026f91d97,g:66a854f2-2067-4b99-a598-319b918d4e4d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cidara.com/role/CoverPage" xlink:type="simple" xlink:href="cdtx-20250807.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://cidara.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_83688800-47e0-43c9-bd50-69efee0d5691" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_DocumentType_83688800-47e0-43c9-bd50-69efee0d5691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d1e55f06-0a81-4b99-96cf-d1183133317d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_DocumentPeriodEndDate_d1e55f06-0a81-4b99-96cf-d1183133317d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8f0f917b-0573-42e9-b553-78b1247a5833" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityRegistrantName_8f0f917b-0573-42e9-b553-78b1247a5833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4f6efeda-8b50-4dbe-b8fe-a86903cb432e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4f6efeda-8b50-4dbe-b8fe-a86903cb432e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8d8edea5-98b3-4c2a-b09c-29a211fc100c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityFileNumber_8d8edea5-98b3-4c2a-b09c-29a211fc100c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_30291143-f0fa-4a99-aee7-1a44700987ba" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityTaxIdentificationNumber_30291143-f0fa-4a99-aee7-1a44700987ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3a913fb0-411b-4c79-b91e-01e6f0ec4a7d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityAddressAddressLine1_3a913fb0-411b-4c79-b91e-01e6f0ec4a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_bbbbc824-9ecb-49dc-b075-84f0da2d9872" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityAddressAddressLine2_bbbbc824-9ecb-49dc-b075-84f0da2d9872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ea7f6fe2-bcba-489d-8bdb-72236a3bd2da" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityAddressCityOrTown_ea7f6fe2-bcba-489d-8bdb-72236a3bd2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_92d968d6-fb95-4f66-a2b7-182dc1d413dd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityAddressStateOrProvince_92d968d6-fb95-4f66-a2b7-182dc1d413dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_da2d493c-5257-44a0-b9c2-fbfe37cdeb2c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityAddressPostalZipCode_da2d493c-5257-44a0-b9c2-fbfe37cdeb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2088442a-96cc-4eb8-b2cf-1e06aadbdbab" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_CityAreaCode_2088442a-96cc-4eb8-b2cf-1e06aadbdbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ed29e328-da28-4421-85da-acca92020b9f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_LocalPhoneNumber_ed29e328-da28-4421-85da-acca92020b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_806cdb40-276b-419a-b76d-6b5cab5bfb98" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_WrittenCommunications_806cdb40-276b-419a-b76d-6b5cab5bfb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_fc0ef2ce-87a9-4932-9217-e0d50d8b7970" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_SolicitingMaterial_fc0ef2ce-87a9-4932-9217-e0d50d8b7970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_8001c96e-f38d-49ee-b963-877e43325fd3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_PreCommencementTenderOffer_8001c96e-f38d-49ee-b963-877e43325fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6eba123b-0b20-44f2-ab8f-664f6f23bd5b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6eba123b-0b20-44f2-ab8f-664f6f23bd5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e083189c-19fb-49a1-becb-6291ce603b68" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_Security12bTitle_e083189c-19fb-49a1-becb-6291ce603b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b8d7239c-ea30-4b2f-bfbb-df9ea332b206" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_TradingSymbol_b8d7239c-ea30-4b2f-bfbb-df9ea332b206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a99b3523-ec7d-4143-8f9b-c7f207d84ca2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_SecurityExchangeName_a99b3523-ec7d-4143-8f9b-c7f207d84ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ac0182c0-0df1-4007-a529-18550ba9ee59" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityEmergingGrowthCompany_ac0182c0-0df1-4007-a529-18550ba9ee59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6c2e2724-5831-47a8-b55e-ed72648f5402" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_EntityCentralIndexKey_6c2e2724-5831-47a8-b55e-ed72648f5402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_85341dee-0b50-4de2-92ba-e72e82aa3e81" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be06ba49-b2ca-4e06-aea1-a4dd645d70e6" xlink:to="loc_dei_AmendmentFlag_85341dee-0b50-4de2-92ba-e72e82aa3e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>cdtxlogoa18a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cdtxlogoa18a.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!817AI9@  34T *@    @ ! ,"  (
M   2    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !S4D="($E%0S8Q.38V+3(N,0#_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#Y;_X*I?MFW'[+'P6ATS0+CR/&'BXR6]E*I^:P@4#S;@>C#<JI_M-NYV$
M5^.5Q<27<\DLKO)+(Q=W<[F<GDDGN37U)_P6.^(-QXS_ &W]:T^21FMO"]C:
M:;;KGY0&A6X?CUWSL/P%?+%?@/&.:5,7F4X-^[3;BEZ:-_-_A;L?TYP%DU/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTL@'^W(SM_P*OT3PZP<YXV>)^S&-OFVOT3_ _*_%;,(4\OIX2_O3E>WE%/\
M5K\3M****_9#\#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI>77[GK^!OT445QGI!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<8_ZSY3_ -!$?O/LZBOD_1/^"U?[/^JNJS^(]8TT-U-SHMRP7_OVKUZ!X/\
M^"DWP)\<R(MC\3O#$+2=/M\S:?\ ^CU3'XUC4RS%PUE2E]S.JEGF757:G7@_
M^WE_F>X45F^%_&>C^.-.%YHNK:;K%H>D]E=)<1G_ ($A(K2KB::=F>E&2DKQ
MV"BBBD4%%%% !1110 4444 %%%% !1110 45SOQ(^+OA7X.Z5!?>+/$FA^&K
M*ZE\B&?4[V.UCEDP6V*SD M@$X'8&N-_X;F^"_\ T5?X=_\ A06O_P 76T,/
M5FN:,6UY)G/4QE"G+EJ32?9M(]4HKRO_ (;F^"__ $5?X=_^%!:__%UJ^"OV
MK?AC\2/$UMHOA_XA>"]<UB\W>196.LV]Q<3;5+MM16+'"JQ.!P 33EA:R5W!
M_<R8X[#2?+&I%M^:_P SOZ***P.H**** "BBB@ HHHH ***1G"*68A549)/:
M@!:*XSQ7^T;\/? A9=;\=>#M'9>JWNLVT##\&<&O._$7_!3?X"^%RWVGXG>'
MI-O7[)YMY_Z)1LUT4\)7G\$&_1-G'6S#"TOXM6,?627YL]WHKY7U?_@L_P#L
M^:8Q$/B[4-0Q_P ^^B7@S_W\C6N?O/\ @NC\#;8_(WC"X_ZYZ2!G_OJ05U1R
M?'/:E+[F<,N(\KCOB(?^!)_D?9%%?%O_  _A^"6?^//QU]?[+A_^/U:LO^"Z
M/P-NV_>-XPM?>320?_09#5?V+CE_RZE]Q"XFRI_\Q$?O/LBBOEW0/^"RG[/>
MMLJR>,KK36;H+K1KP?JD3 ?B:],\#?MS_!WXCR)'H_Q*\&SS2?<AEU..WF?Z
M1R%6/Y5SU,OQ5/6=.2^3.NCG& K.U*M!ORDO\SU:BH[6ZCO;=)H9(YH9!N1T
M8,K#U!'6I*XST@HHHH **** "BBB@ HHHH **** "BBL_P 6>+M+\!^';K6-
M;U*QTC2K%/,N;R\G6&"!<@99V("C) Y/>FDV[(4I**N]C0HKRO\ X;F^"_\
MT5?X=_\ A06O_P 71_PW-\%_^BK_  [_ /"@M?\ XNM_JE?^1_<SD_M#"_\
M/V/_ ($O\SU2BO+[7]MSX.7UU'##\5/A[+-,P1$77[4L[$X  W]2:]0K.I2G
M#XTUZJQM1Q%*K_"DI6[-/\@HHHK,V"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P U^*UZ,]_HHHKY4^_"BBB@ J&_OX-*L9KJZFAMK:W0R2RRN$CB0#)9F/
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M^/K#]HWP3X:\(^+/$.A0Z]K=K:7$-G>.D#1/*OFL\6=C )N/*GI7[Z5^+?\
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M_L4[3_TINZ^FX3_W_P"3/B/$#_D4O_%']3XEHHHK]./PH_I(^'G_ "(&A_\
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MF&TDG]_3Y;!1117.=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;<XC5AZ/,P8>\!K\HZ_2.$<'[/"NN]YO\%_P;GXGXB9E[;'1PL=J:U]9:O\
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MX3NU;Z?:;0_S K]AJ_+N*HI9A)]TORM^A^\< U'+*(I])27XW_4****^</M
MHHHH *;+*L,;.[*J*"S,QP !W-.KYV_X*G_'[_AGW]BWQ5>6\WDZMXBC&@Z<
M0<-YEP&5V![%81*P/JHK;#4)5ZL:,=Y-(Y<=BH8;#SQ%3:*;^X_'[]MWX]-^
MTK^U-XR\7+(TEC?7[0Z=GH+2+$4'';,:*Q'JQKRFBBOVJC2C3@J<-DDE\C^8
M\17G7JRK5-Y-M^KU/K;_ ((N_ ;_ (7#^V;I^KW4/F:7X%MGUF4L/E,_^KMU
M_P!X2-Y@_P"N)K]E_&OA&Q^('@[5M!U2'S]-UJSFL+J,_P#+2*5"CC\58U\>
M_P#!#+X#?\*T_91N?%EU#Y>H^/KYKE6(PWV2 M%"#]7\]QZB05]JU^7\1XUU
ML?+E>D-%\M_QN?O'!>6+#93'G6M3WGZ/;\+'\X?Q@^&E]\&OBKXB\)ZD#]N\
M.ZC/I\IQ@2&-RH<>S !AZ@BN;K[E_P""[_P&_P"$ _:8TOQK:P[+'QU8#SV
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MU\_5] _\%3_^4@'Q*_Z_X?\ TFAKY^K]HRW_ '2E_AC^2/YESG_D85_\<O\
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M])H:^?J^@?\ @J?_ ,I /B5_U_P_^DT-?/U?M&6_[I2_PQ_)'\RYS_R,*_\
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MI+F*<8[XC=B!Z@5_0;!.ES"DD;+)'(H964Y5@>00:_FAK]T?^"4GQ^_X7_\
ML5^%[BXF\[5O#*G0-0R<MOMPHC8]R6@:%B3U):OG^,<'>,,5'IH_S7Z_>?8>
M&^96G4P,NOO+U6C_  M]Q]'T445\$?K04444 %?CS_P7L_Y/2TG_ +%.T_\
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M!P2:^=QW$V#H*U-\\NRV^_;[KGVF5<"YEBVI5E[./>6_RCO]]CXF_P""=_\
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M;>*=2UK4IFN=1U:ZEO;J5NLLLCEW8_5B36?117[,DDK(_FB4FW=GWE_P04^
MW_"9_M Z]X\NH=UGX,L/LUHQ'_+W=!DR#WVPK,#Z>8M?K=7S-_P2/^ W_"B_
MV)O#9N(?)U3Q;N\07F1AOWX7R1Z\0+%QV):OIFOR3/\ &?6,;.2V6B^7_!NS
M^A^$<N^IY73@U[TES/U>OX*R^04445XQ](%-FA6XA:.15DCD!5E89# ]013J
M* /Y[?VS/@8_[-W[3_C/P?Y;1VFEZB[6.?XK23$L!SW_ '3H#[@UYC7Z0_\
M!P'\!OL7B'P9\2K2'$=]&V@:BX& )$W2VY/J64S#/I&HK\WJ_8LIQGUG"0J]
M;6?JM&?S;Q%EWU',:N'6R=UZ/5?@['O'_!-/X_?\,Z?MD^$-8GF\G2M2N/[&
MU,DX7[/<83<W^RDGER?]LZ_>BOYGP<&OW[_X)_?'W_AI/]D?P;XFFF\[5/L8
ML-3).6^UP?NI&;T+E1)])!7RW&.#UABH_P"%_FOU/OO#;,M*N!E_B7Y/]/Q/
M9:***^&/U0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBH[J[BL;:2:
M:2.&&,%G=V"J@'<D\"@"2BO/=7_:U^%7A^[-O?\ Q,^'UC.IP8Y_$5G&X/T:
M0&NB\%_%OPK\2 ?^$=\3>']>VC)_L[48;K _[9L:TE1J17,XNWH81Q5&4N6,
MTWVNCH****S-PHHHH **** "BBFRRK!$TDC*B("S,QP% ZDF@!U>$_M-_P#!
M1GX8?LM2S6.L:NVK>((ASH^E 7%S&?20Y"1=N'8-@Y -?(/_  4/_P""MM]X
MAU&^\$_"G4'LM*A+07_B&W;;->D<,ELW\$8_YZ#YF_A(7EO@&:9[B5I)&:22
M0EF9CDL3U)-?FO$''L:$WA\O2DUO)[?)=?7;U/UOA?PSGB(+$YHW&+U4%I)K
M^\^GIOZ,^ZOBI_P7:\<:Y<R1^#_"GA_P_:9(66_>2_N,=CP8T4GT*MCU/6O)
M]2_X*Y_'Z^N"\?C:&S7.1'#HMCM'_?4+']:^:Z*_/<1Q-FM:7-*O)>CY?P5C
M]1PO"&2T(\L,-!_XES/[Y79]6>$?^"S7QQ\-W"O>ZIH/B!5/,=_I,4:M_P!^
M/*/ZU]&? W_@NQX?UVYAL_B#X5NM!9R%;4=*D-W;@^K1,!(JC_9,A]J_,>BN
MC!\79KAY759R7:7O?GK]S1SX[@?),5&TJ"B^\?=:^[3[TS^A/X8_%CPU\9_"
ML.M^%=:T_7M+FX$]I*'"MW5AU1AW5@".XKH:_ /X!_M&>,/V9_&\6O>#]7FT
MVZ4@3PD[K:]0'_5S1]'7KUY&<@@X-?L/^PU^W5X>_;/\"M-;K'I7BK2T7^U=
M(:3<T6>/-B/5XF/?JIX/8M^I\-\7T,R?L:JY*O;H_3_+?U/QCBS@7$Y0OK%%
M^TH]^L?\2_5:=[:'NM%%%?8GP04444 0ZGJ5OHVFW%Y=S1V]K:QM--+(VU(D
M4$LQ/8  DFOP_P#V]OVO;_\ :_\ CE>:L)9H_#.EL]IH5HV0(K<'_6E?^>DA
M 9NX^5<D**_1_P#X+!_&N7X2_L=ZAI]G,8;_ ,9W4>BJ5.&6%@TDY^AC0QG_
M *ZU^.5?DWB)F\G4CEU-Z)<TO-]%\M_FNQ^W>%>1P5*>:U5[S;C'R2W?SV^3
M[A1117Y@?L04444 %%%% 'V)_P $BOVS[CX&_&"'P+K5VW_"(^,;A88O,;Y=
M.OFPL<@]%D.(V]RC<;3G]<*_G-BE:"571F1T(964X*D="#7[R?L9_&9_V@/V
M7_!?BR:3S+W4=/6.];^]<Q$PS'VS)&QQZ$5^N^'F;RJTYX"H[\NL?39KY.UO
M4_#/%/(X4:L,SI*W.^67^)*Z?JTG?T/3J***_2S\B"BBB@ HHHH **** "OY
M\_VX_!S> OVQ?B;I>WRTA\27LL2XZ12S-+'_ ...M?T&5^+W_!;WX;-X(_;E
MOM46/;#XMTFTU-2!\I9%-LP^O[@$_P"]GO7UO!];EQ4J;^U'\G_PY^>^(^'<
M\!"LOLR_!I_JD?(%;7PX\4MX&^(>@ZVN[=H^HV]\,=<Q2J__ ++6+17Z-**:
MLS\7C)QDI+=']+T$Z7,"21LKQR*&5@>&!Y!%.KRK]ASXFK\8/V0OAWX@\SS9
MKK0[>&X?.=T\*^3-_P"1(WKU6OQ"M3=.I*F]TVON/ZDP]:-:E&M':237S5PH
MHHK,V"BBB@ HHHH **** "BBB@ HHHH _"#_ (*G_P#*0#XE?]?\/_I-#7S]
M7T#_ ,%3_P#E(!\2O^O^'_TFAKY^K]HRW_=*7^&/Y(_F7.?^1A7_ ,<O_2F>
MI?L._P#)YWPG_P"QNTO_ -*XJ_H.K^?']AW_ )/.^$__ &-VE_\ I7%7]!U?
M$\9?QZ?H_P S]0\-?]UK?XE^04445\:?I05^+?\ P6__ .3\=2_[ ]C_ .@&
MOVDK\6_^"W__ "?CJ7_8'L?_ $ U]1PC_OS_ ,+_ #1\'XB?\BI?XU^3/D.I
M;'_C]A_WU_G452V/_'[#_OK_ #K],/Q".Y_2W1117X6?U6%%%% !1110 444
M4 %?./\ P5G^(B_#K]@CQW()-MQK$,.DP#.-YGF1''_?KS#^%?1U?FQ_P<%_
M&M(M(\"_#NWF!DFED\07T8/*JH:"WS[$M<?]\"O5R3#NMCJ</.[]%J>!Q1C%
MALKK5'NXM+UEI^MS\QJ***_7S^<CZ_\ ^"'O@T^)_P!NZPOMFY?#NC7VH$X^
MYN1;;_VXQ^-?M#7YF_\ !O7\,F,WQ&\92Q_*%M=%MGQU/S33#\,0?G7Z95^6
M\4UN?'M+[*2_7]3]YX"PSI91&3^VY2_&WZ!65XZ\96/PZ\%:QX@U27R--T.R
MFO[J3^Y%$A=S^2FM6OC#_@N)\?O^%6?LFQ^%K6;R]4\?7@L\ X86D.V6=A]3
MY*'U$IKR,#A7B<1"@OM/\.OX'T>;8Z."P=3%2^RF_GT7S=D?DC\7_B9?_&;X
MJ>(O%FJ-F^\1:A-?S#.1&9'+!!_LJ"%'H *YRBBOV>,5%*,=D?S+4J2G)SEJ
MWJST3]E+XT:;^SO\?_#GC;5-!;Q-!X=G:[BT];H6OF3!&$3ERCXV.5?[O)05
M]Z?\1$5I_P!$EN/_  I!_P#(M?F/17GXS*,)BYJ=>-VE;=K\F>SEO$689?3=
M+"3Y4W=Z1>NV[3?0_3C_ (B(K3_HDMQ_X4@_^1:/^(B*T_Z)+<?^%(/_ )%K
M\QZ*X_\ 5G+?^??XR_S/1_UXSK_G]_Y+#_Y$_3C_ (B(K3_HDMQ_X4@_^1:/
M^(B*T_Z)+<?^%(/_ )%K\QZ*/]6<M_Y]_C+_ ##_ %XSK_G]_P"2P_\ D3].
M/^(B*T_Z)+<?^%(/_D6OF_\ X*)?\%%])_;RT'PU&O@2;PSJOANXF:.\;5A=
MB6&55WQ%1"G\21L#DXPW'.:^5Z*WPV18+#U%5I0M);.[_P SEQO%>:8NC+#X
MBIS1ENN6/KT5]PHHHKUSYT_9K_@B/\?O^%L_LB+X;NIO,U3P#=MIS G+&UDS
M+;L?89DC'M#7V-7XM_\ !%;X_?\ "GOVQ;30[J;R]*\>VS:1(&.%%R/WENW^
M\6!C'_78U^TE?E/$>#^KXZ5MI>\OGO\ C<_H#@O,OK>5PYOBA[K^6WX6"BBB
MO!/K K\>?^"]G_)Z6D_]BG:?^E-W7[#5^//_  7L_P"3TM)_[%.T_P#2F[KZ
M;A/_ '_Y,^(\0/\ D4O_ !1_4^):***_3C\*/Z+-'^&?AOQU\/\ 0QKGA_0]
M9!TZW!%]8Q7&1Y:_WU-<YJ_["?P7UQRUQ\*_ .YNIBT.WA)_[X45W_P\_P"1
M T/_ +!]O_Z+6MBOQ/ZQ5@WR2:]&S^H/J="I!.I!/1;I,\1D_P"";OP)E.3\
M+_"OX6Y7^1K\QO\ @K'^P,/V2OBI'XA\-6;1^ /%4I-HJY9=*NL;GM2?[I&7
MCS_#N7G82?VGKC?C]\#=!_:0^$>M>#?$EOYVF:S 8RZ@>9;2#F.:,]G1@&!Z
M<8.02#ZF5YW7PU=3J2<H[--MZ=UYK_@'A9]POA<;A)4J,(PFM8M)+7L[='M^
M/0_G1HKNOVDOV?=>_9>^,FL^"_$46V]TN7]U.JD17L#<QSQ^JNO/L<@\@BN%
MK]6IU(SBIP=T]4?@%:C.E-TZBM).S79H_5S_ ((K_M\_\+&\+Q?"/Q9>[M>T
M. MX?N9G^:_M$'-N2>LD0&5]8Q_TS)/Z"5_-EX,\9:I\//%NFZ[HMY-IVK:3
M<)=VES"</#(A!5A^(Z'@]#Q7[P?L$?MD:7^VE\"K/Q!#Y-KX@T_;::[8(?\
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M-?DSY#J6Q_X_8?\ ?7^=15+8_P#'[#_OK_.OTP_$([G]+=%%%?A9_584444
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M%/!1>LGS/T6WWO\ (J5J>"O!^H_$/QCI6@Z1;M>:KK5W%8V<"G!EFD<(BY/
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MMBFU%-)6:5WN]T]M/O/Q/_X<K?M ?]"UI/\ X.K7_P"+H_X<K?M ?]"UI/\
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MF"BOQP_8C_X+*^,/V<M/L_#?C2WN/&WA&V B@=I<:EIT8X"QR-Q*@'1),$<
M.H&*_27X#_\ !0[X/_M%6T(T#QII=OJ,P'_$LU.06-ZK?W0DF-Y'K&6'O7YC
MF&1XO"2?-'FCW6J^?;YG[ID_%67YA%<DU&?\LM'\N_R_ ]JHH!W#(HKQSZ0*
M*** "BFR2K#&S.RJJC)8G  KA?&G[4WPT^'0;^W?B!X-TITZQW.L6Z2'Z)OW
M'Z 5<*<YNT$WZ&=2M3IKFJ227F['>45Y;\%OVU/AC^T5XXOO#O@GQ7:^(-6T
MVT-[<1V]O,J)$'5-PD9 C?,ZC"DGFO4J=2C.G+EJ)I]FK$T,12K1YZ,E)=TT
MU]Z"BBBLS8_"#_@J?_RD ^)7_7_#_P"DT-?/U?0/_!4__E(!\2O^O^'_ -)H
M:^?J_:,M_P!TI?X8_DC^9<Y_Y&%?_'+_ -*9ZE^P[_R>=\)_^QNTO_TKBK^@
MZOY\?V'?^3SOA/\ ]C=I?_I7%7]!U?$\9?QZ?H_S/U#PU_W6M_B7Y!1117QI
M^E!7XM_\%O\ _D_'4O\ L#V/_H!K]I*_%O\ X+?_ /)^.I?]@>Q_] -?4<(_
M[\_\+_-'P?B)_P BI?XU^3/D.I;'_C]A_P!]?YU%4EHXCNHV;A5<$G\:_3#\
M06Y_2Y17F/@G]M7X1_$1%_L?XE>"[J1^D+:M##,?^V;LK_I7HNEZS9ZY;":R
MNK:\A/22"59%/X@D5^'U*-2#M.+7JK']2T<32JJ]*2EZ-/\ (LT44$XK,V"B
MN+\>_M(?#[X70N_B+QOX4T7R^J7FJPQ2'V"%MQ/L 37S7\;?^"X'P<^&L$T/
MAV35_'6HID(EA;M;6N[T::8*<>Z(]=F'R_$UW:E!OY:??L>;C,XP.%5\15C'
MYJ_W;_@?9&:^$O\ @HS_ ,%?M'^#&G7_ (-^&-]:ZWXRD#076JQ$2V>BGH=I
MY66<>@RJ'[V2"E?%G[6/_!6?XI?M16MSI,=Y'X.\+W */IFD.RO<(?X9IS\\
M@(X*C8A'5:^7Z^RRGA3DDJN,U_NK;YOKZ?B?FO$'B ZD70RVZ3WF]'_VZNGJ
M]?);EC5]7NM?U6YOKZYGO+V\E:>XGG<R232,26=F/)8DDDGDDU7HHK[8_+VV
M]6%?L]_P1Y_8GD_9G^![^*/$%GY'C'QQ''/+'(F)-.LA\T,!SRK-GS''')12
M,I7S/_P2*_X)ES_$76M.^*GC[3VC\-V+K<:#IMPF#JLJG*W$BG_E@I&5!_UA
M /W!\_ZM5\%Q1G"G_L=%Z?:?Z?Y_\.?K? ?#<J?_  I8E6;7N)]G]KY[+RU[
M!1117Q!^HGY\_P#!??X_?\(W\)_"_P .;.;;<^)KHZIJ"J>1:P'$:L/1YFW#
MW@K\I:]\_P""FGQ^_P"&BOVR_%VK03>=I.DS_P!BZ80<KY%L2FY3_=>3S)!_
MUTKP.OU[(\']6P4(/=ZOU?\ EM\C^=.*LR^NYG4JI^ZGRKT6GXN[^85^TW_!
M%?X"_P#"H/V-K/6KJ'R]4\>73ZO(6'S"W'[NW7_=**9!_P!=C7Y"? OX4WGQ
MS^,GAGP?I^X77B+48;$.!GR5=@'D/LB[F/LIK^B?POX;L_!GAG3M'TV%;?3]
M)M8K.UB7I%%&@1%'T4 5X?&&,Y:4,,OM.[]%M^/Y'U7AOEO/B*F-DM(KE7J]
M_N7YEZBBBOST_80HHHH **** "BBB@#/\5^&;/QKX7U+1M2A6XT_5K66RNHC
MTEBD0HZ_BI(K^=GXX?"N]^!WQA\3>$-0W&Z\.ZC-8LY&/-5'(60>SKM8>S"O
MZ-J_)'_@O5\!/^$*_:"T+QY:0[;/QI8_9[ME'_+Y;!4R3VW0M"!Z^6U?7<(X
MSV>)E0>TEIZK_@7/SSQ$RWVN"CBXK6F]?26GYV^]GP;7T)_P2Z^/W_#/7[:'
MA/4+B;R=)UZ4Z%J))POE7!"JS'^ZDPB<GT0U\]TJ.T;AE)5E.00>0:_0,10C
M6I2I3VDFOO/R#!8J>&Q$,13WBT_N/Z7Z*\E_88^/:_M*_LJ>#?%DDPFU"ZL5
MMM2.>1=PYBF)';<Z%P/1Q7K5?BM:E*E4=.>Z;3^1_3F&Q$*]*-:GM))KT:N%
M?CS_ ,%[/^3TM)_[%.T_]*;NOV&K\>?^"]G_ ">EI/\ V*=I_P"E-W7T7"?^
M_P#R9\=X@?\ (I?^*/ZGQ+1117Z<?A1_21\//^1 T/\ [!]O_P"BUK8K'^'G
M_(@:'_V#[?\ ]%K6Q7X;/XF?U12^!>@4445)H%9?C?P5I?Q(\'ZEH&N64.H:
M1K%L]I=VTHRLT;C##VZ\$<@X(YK4HIQDT[HF45)<LMF?@+^W9^R!JG[&'QXO
MO#=UYUUHMUF[T2_<<7EJ2<9/3S$/RN..1G&&7/C-?OA^W]^QMIO[:7P'N]!<
M0V_B+3=UYH5\X_X]KD#[C'KY<@&UA_NM@E17X/\ BWPIJ7@3Q1J&BZQ9S:?J
MFE7#VEW;3+MD@E1BK*1Z@@U^JY#FRQM"T_CCOY^?S_,_ >+>'WEF*O37[J>L
M?+O'Y=/+YE!':-PRDJRG((/(-?M#_P $E/V]Q^U5\*?^$7\1W@?Q[X3@5+AY
M&^?5K085+D>KCA9/]HJW\>!^+M==\"OC9KW[._Q7T7QAX;N?LVK:+.)4SGRY
MTZ/$X[HZDJ1Z'L<&NC.,KCC:#A]I:I^?^3.3AO/IY7BU5WA+22[KOZK=?=U/
MZ,J*\^_9>_:.T']JSX+:1XS\/R8M]039<VS,&DL+E<>9 _\ M*3UXW*58<,*
M]!K\DJ4Y4Y.$U9K1G]#T:T*M-5:;O&2NGW3"OG3_ (*I_'[_ (9^_8L\575O
M-Y.K>(T&@:>0<-YEP&$C ]05A$S CNHKZ+K\E_\ @O;\?O\ A,?CMX?^']G-
MNL_!]E]LO54_\O=R P4C_9A6,C_KLU>KD.#^LXV$'LM7Z+_-V1\_Q9F7U++*
ME1/WI>ZO5Z?@KOY'P/110!DU^N'\[GZ5?\&_?P$\Z^\9_$N\A^6%5\/Z:[#^
M([9K@CW \@ C^\PK]-J\@_8+^ W_  S;^R9X+\+2P^3J,-BMWJ0(^;[7/^]E
M!]=K/L!]$%>OU^/YQC/K.,G56U[+T6G_  3^C^&\M^HY;2H->]:[]7J_NV^0
M4445Y9[H4444 %%%% !1110!^&O_  5I^ G_  H?]M?Q,MO#Y.E>*R/$%E@8
M7$Y;S@.W$ZRX Z#;7S37ZW?\%Z_@)_PFG[/^@^/+2'=>>#+[[-=LH_Y=+DJF
M2?\ 9F6(#T\QJ_)&OUS(<9]8P4)/=:/U7_ LS^=^+<M^IYI4@E[LGS+T>OX.
MZ^1T'PH^(^H?!_XG>'_%6EMMU#P]J$.H0<X#-&X;:?\ 9;&".X)K^BCX?>-[
M#XF>!-%\1:7)YVFZ]8PZA:O_ 'HI4#KGWPPK^;>OV,_X(:_'[_A9_P"RG<>$
M[J;S-2\ WIME!.6-G.6EA)^C><@]!&M>/QA@^>A'$+>+L_1_\'\SZ3PYS+V>
M*G@I/2:NO5?YJ_W'VI1117YV?L@4444 %%%% !1110 4444 %%%% &3X\\+1
M^.? VM:),VV'6+&>Q<D=%EC9#_Z%7\X.OZ'=>&-=O=-OH6M[W3[B2VN(FZQR
M(Q5E/T((K^E2OQK_ ."TW[)EQ\$OVD)O&VGVK#PS\0)&NS(B_);:AC,\9/8N
M?WHSUWN!]TU]CP?C(PK3P\OM*Z]5_P #\C\W\1LMG5PU/%P7P-I^DK:_)JWS
M/C.BBBOT,_&PHHHH ***DL[.;4;R*WMXI)[B=Q'''&I9Y&)P% '))/  H _1
M/_@WM^',UU\0OB%XN:-EM['3K?2(W(X=II/-<#_=$"9_WA7ZDUX/_P $X?V6
M6_9)_98T3P_>QK'X@U$G5=:QSMNI0O[O/_3-%CCXX)0D=:]XK\ASO&+$XV=2
M.VR]%I^.Y_1G"^72P664J%16E:[]6[V^6WR"BBBO)/H#Q'_@HW\-9/BM^Q3X
M_P!,@C,EU;Z?_:4(498M;.MP0/<K&R^^ZOPYK^C&XMX[NWDAE19(I5*.C#*L
M#P01Z&OPF_;:_9RN?V6_VCO$'A=HY%TWSC>:3*W2:RD),1![E>48_P!Z-J_*
M?$C+Y<U+'16EN5_FOS9^U>$^:1Y:V72>M^=>>RE]UE^)Y/1117Y:?LP4444
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MI9=5KQ^*UEZO1?=O\C\UR=QR:*L?V1=_\^MQ_P!^C_A1_9%W_P ^MQ_WZ/\
MA7[!='\Y<K/NS_@@G\!/^$R^/NO>/KN'=9^#;'[+9LP_Y>[D,N0?]F%90?3S
M5K];*^:_^"3?P#/P$_8I\,QW,'DZMXI#>(+X%<,#.%\I3W&(%B!!Z'=7TI7Y
M'GV,^L8V<ELM%Z+_ (-V?T-PEEOU+*Z=-KWI>\_5Z_@K+Y!1117CGT@4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOA;J%VO\+7>NI;G\0L#_ ,ZPQ_P<0:AYO_)*;/R^X_X2%L_G]G_I0!^GE%?
M_P (_P#@OU\/_%>IPVOB[PGKWA%9F"FZMYUU.WA]WPL<F/\ =1C[5]P> ?B!
MHGQ2\(V.O>'=4LM9T;4H_,MKNUE$D<HZ'D=""""#R""" 010!L4444 %%%%
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M#V.(XS[35^<O_!,+X-?\+O\ VWO VG2P^;8Z5>?VU>9&5$=J/-4-[-(L:?\
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M5M \C_"_Q<J1J68_8CP!UKR'0M;NO#.MV>I6,SV]]I\Z7-O*OWHI$8,K#W!
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M&&Q_Z^(__0A7]*E?S>_"OP]-XN^)_AO2;=6>XU35+6TC4#EFDE5 /S-?TA4
M%%%% !1110!^67_!PO\ \E,^&O\ V#+S_P!&QUY%_P $2O\ D_C1?^P7?_\
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M8>Q'%25_.1\+OC?XP^">LIJ'A'Q-K7AVZ5@Q:QNWB63V=0=KCV8$'TK]+?\
M@GE_P6;7XIZ]8>"?BQ]BT_6KQE@T_7XE$-O>R'A8[A!\L;L> ZX0DX(7J>3,
M.%L1AX.I2?.EOI9_=K^9Z.3<>X/&5%1KQ]G)[7=XOYZ6^:MYGZ%4445\N?=A
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7F_[9/\ R:%\5O\ L3]7_P#2*:O2*IZ_H-EXJT&^TO4K6"^T[4K>2UNK
M:9 \=Q$ZE71@>"K*2"#U!H _FKK^A+]BG_DS?X3?]B;I'_I%#6=_PP!\$?\
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M&OWXK@_B;^RY\.?C1X@CU;Q9X)\->(M3B@6V2ZO[".:58E+,$W,,X!9CCW-
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M/_ :^>]*T?QI^T_\6C#:PZQXO\8>)+DR.1F:XN9#U=B>BCNQPJ@=@*_9P?\
M!(#]G5;L3?\ "NUW YV_VWJ)0G_=^T8_#I7LOPB_9\\#_ 33)+3P;X5T3PY%
M, )6LK58Y9\=/,D^^^/]HF@#@/\ @GO^R2O[&O[-VF^%[B2&XUV\E;4M9GBY
MC>ZD"@JIZE4140'OM+8&[%>X444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ74M8U.0*BJ/DA3^*61NB1J.2QZ#WP*F<XPBY2=DBZ=.=22A!7;T274^\O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Aug. 07, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  07,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cidara Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-1537286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6310 Nancy Ridge Drive,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">752-6170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.0001 Per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CDTX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001610618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cdtx-20250807.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cidara.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cdtx-20250807.htm">cdtx-20250807.htm</File>
    <File>cdtx-20250807.xsd</File>
    <File>cdtx-20250807_lab.xml</File>
    <File>cdtx-20250807_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cdtx-20250807.htm": {
   "nsprefix": "cdtx",
   "nsuri": "http://cidara.com/20250807",
   "dts": {
    "inline": {
     "local": [
      "cdtx-20250807.htm"
     ]
    },
    "schema": {
     "local": [
      "cdtx-20250807.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cdtx-20250807_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cdtx-20250807_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://cidara.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cdtx-20250807.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cdtx-20250807.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cidara.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001610618-25-000080-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001610618-25-000080-xbrl.zip
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M/>21,6"HO9L5QZQ71\GQF/O)H&E;UM\*JFGK1(XH\$1?X*+IWWJ<E=%0JQD
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M0 " _)RSVWAOE%;V\4I<0Y3 507 ED&$;15:;2 L-(\XW1<TUS%,%_Z;CW1
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MKR^W)_>0#XB4U+2K3^?MRWJ7UAO]#/L=BPZ7;/?_8A&=8;?=B\$S4$L#!!0
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MRB@+4WN02?K?/6BGRL_$\N(N'XXE'H"ED_L#8MEE_"!8XJ-@B7\^EM@%2SP
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M/EM+OJ+W[^1XR+B7 "QN\L4+A@&WNMS\*QR^87'D++VL8-=3];KAE],QCX:
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MLJL@<(EV%U$Z9&<NZ' 9)R"Z2/6CJXNSXXI VR+0N0=L#Z8[Q+%<%J9]3SI
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ME0XQCCVZN#H_1N^Y0$>E$B**;L'N#_)0-E*A;!Y/J="(_:T#7PB+X/%?4U_
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M< '"*S1=MQ'N^KP@J%754N\LN+HXRU"2=X(_MI57;?J'?ZS:]CC; 7XVW8Q
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M 5!+ 0(4 Q0    ( "N!!UOB[8R8@0\  +AO   1              "  0
M  !C9'1X+3(P,C4P.# W+FAT;5!+ 0(4 Q0    ( "N!!UMN&\3;8P(  /0&
M   1              "  ; /  !C9'1X+3(P,C4P.# W+GAS9%!+ 0(4 Q0
M   ( "N!!ULW[2%*8 H  !19   5              "  4(2  !C9'1X+3(P
M,C4P.# W7VQA8BYX;6Q02P$"% ,4    "  K@0=;4=<A$=,&  #X,@  %0
M            @ '5'   8V1T>"TR,#(U,#@P-U]P<F4N>&UL4$L! A0#%
M  @ *X$'6[6\S^LZ'@  340! !,              ( !VR,  &5X.3DQ,C R
A-2TP.'@P-RYH=&U02P4&      4 !0!% 0  1D(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>cdtx-20250807_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cdtx-20250807.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610618</identifier>
        </entity>
        <period>
            <startDate>2025-08-07</startDate>
            <endDate>2025-08-07</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001610618</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-08-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Cidara Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-36912</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">46-1537286</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">6310 Nancy Ridge Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 101</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">San Diego,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">752-6170</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, Par Value $0.0001 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">CDTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
